BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 9.56% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 8.40% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.23% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 5.81% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 5.14% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.98% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 4.81% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.31% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.10% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.99% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.99% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.85% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 2.98% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 2.96% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 2.77% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.32% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.08% |
| PACB | Pacific Biosciences of California | Healthcare | Medical Devices | 1.83% |
| PRME | Prime Medicine, Inc. Common Stock | Healthcare | Biotechnology | 1.64% |